抗心律失常药物的风险效益评估。流行病学视角。 - Suppr

Suppr

超能文献

Risk-benefit assessment of antiarrhythmic drugs. An epidemiological perspective.

作者信息

Friedman L, Schron E, Yusuf S

机构信息

Clinical Trials Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland.

出版信息

Drug Saf. 1991 Sep-Oct;6(5):323-31. doi: 10.2165/00002018-199106050-00002.

DOI:10.2165/00002018-199106050-00002

PMID:1930738

Abstract

摘要

相似文献

Risk-benefit assessment of antiarrhythmic drugs. An epidemiological perspective.抗心律失常药物的风险效益评估。流行病学视角。

Drug Saf. 1991 Sep-Oct;6(5):323-31. doi: 10.2165/00002018-199106050-00002.

[Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study].

Z Kardiol. 1992;81 Suppl 4:145-9.

Antiarrhythmic drug trials: what lessons have we learned?抗心律失常药物试验：我们学到了什么经验教训？

Indian Heart J. 1997 Jul-Aug;49(4):435-8.

[Cardiac arrhythmia suppression trial (CAST)].[心脏心律失常抑制试验（CAST）]

G Ital Cardiol. 1990 Feb;20(2):171-6.

Clinical evaluation of the efficacy of antiarrhythmic drugs.抗心律失常药物疗效的临床评估

Cardiologia. 1983 Sep;28(9):739-46.

[Cardiac Arrhythmia Suppression Trial: a disappointment?].[心律失常抑制试验：令人失望？]

Arq Bras Cardiol. 1990 Sep;55(3):153-4.

Statistical problems in the design of antiarrhythmic drug trials.抗心律失常药物试验设计中的统计学问题。

J Cardiovasc Pharmacol. 1992;20 Suppl 2:S114-8.

Clinical trials in the evaluation of antiarrhythmic drugs: design, drugs, and double-blind considerations.抗心律失常药物评估中的临床试验：设计、药物及双盲考量

Ann N Y Acad Sci. 1984;432:103-7. doi: 10.1111/j.1749-6632.1984.tb14512.x.

[Methodology in clinical trials of anti-arrhythmia agents in ventricular arrhythmias. Analysis and perspective following results of the CAST study].[抗心律失常药物治疗室性心律失常的临床试验方法学。CAST研究结果后的分析与展望]

Arch Mal Coeur Vaiss. 1991 Feb;84 Spec No 2:35-40.

Risks and benefits of antiarrhythmic therapy.

N Engl J Med. 1994 Sep 22;331(12):785-91. doi: 10.1056/NEJM199409223311207.

本文引用的文献

The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug project.冠心病的自然史：2789名男性心肌梗死后康复的预后因素。冠心病药物研究项目的5年研究结果。

Circulation. 1982 Aug;66(2):401-14. doi: 10.1161/01.cir.66.2.401.

Sudden coronary death: the Framingham Study.

Ann N Y Acad Sci. 1982;382:3-21. doi: 10.1111/j.1749-6632.1982.tb55203.x.

Sudden death--definition and epidemiologic considerations.猝死——定义及流行病学考量

Prog Cardiovasc Dis. 1980 Jul-Aug;23(1):1-12. doi: 10.1016/0033-0620(80)90002-x.

The chronology and suddenness of cardiac death after myocardial infarction.心肌梗死后心脏性死亡的时间顺序及突发性

Ann N Y Acad Sci. 1982;382:465-73. doi: 10.1111/j.1749-6632.1982.tb55238.x.

Short-term risk factors for sudden death.

Ann N Y Acad Sci. 1982;382:22-38. doi: 10.1111/j.1749-6632.1982.tb55204.x.

Risk factors for sudden death after acute myocardial infarction: two-year follow-up.

Am J Cardiol. 1984 Jul 1;54(1):31-6. doi: 10.1016/0002-9149(84)90299-6.

The epidemiology of sudden unexpected death: risk factors for men and women in the Framingham Heart Study.猝死的流行病学：弗明汉心脏研究中男性和女性的危险因素。

Am Heart J. 1984 Jun;107(6):1300-6. doi: 10.1016/0002-8703(84)90302-8.

Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death.心脏缺血性猝死中的血栓形成与急性冠状动脉病变

N Engl J Med. 1984 May 3;310(18):1137-40. doi: 10.1056/NEJM198405033101801.

Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation with special reference to preceding arrhythmic events.

J Am Coll Cardiol. 1983 Nov;2(5):789-97. doi: 10.1016/s0735-1097(83)80224-1.

An epidemiological perspective of sudden death. 26-year follow-up in the Framingham Study.

Drugs. 1984 Oct;28 Suppl 1:1-16. doi: 10.2165/00003495-198400281-00002.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验